Ocular Therapeutix Q1 2025 10-Q Filed
Ticker: OCUL · Form: 10-Q · Filed: May 5, 2025 · CIK: 1393434
| Field | Detail |
|---|---|
| Company | Ocular Therapeutix, Inc (OCUL) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, derivatives
Related Tickers: OCUT
TL;DR
OCUT Q1 10-Q is in. Derivative gains/losses and balance sheet changes detailed.
AI Summary
Ocular Therapeutix, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported a Derivative Gain/Loss on Derivative and Other Net, with specific figures linked to financial instruments. The filing also details changes in its balance sheet, including movements in Additional Paid-In Capital and Retained Earnings as of March 31, 2025.
Why It Matters
This filing provides investors with an update on Ocular Therapeutix's financial position and performance for the first quarter of 2025, including details on derivative financial instruments.
Risk Assessment
Risk Level: medium — The company's financial health and future prospects are subject to the performance of its pharmaceutical products and the volatility of financial instruments.
Key Numbers
- 159262024 — Derivative Gain/Loss on Derivative and Other Net (Financial performance indicator for the period.)
- 157749490 — Derivative Liabilities Noncurrent (Indicates long-term financial obligations related to derivatives.)
Key Players & Entities
- OCULAR THERAPEUTIX, INC (company) — Filer
- 20250331 (date) — Period of Report
- 15 CROSBY DRIVE (address) — Business and Mail Address
- BEDFORD, MA (location) — Business and Mail Address
- 781-357-4000 (phone_number) — Business Phone
- I-THERAPEUTIX INC (company) — Former Company Name
- 20070315 (date) — Date of Name Change
FAQ
What was the net gain or loss on derivative and other financial instruments for the period ending March 31, 2025?
The filing indicates a Derivative Gain/Loss on Derivative and Other Net of 159,262,024 for the period.
What is the company's business address?
The business address is 15 Crosby Drive, Bedford, MA 01730.
When did the company change its name from I-Therapeutix Inc?
The company changed its name from I-Therapeutix Inc on March 15, 2007.
What are the key balance sheet components mentioned for March 31, 2025?
Key balance sheet components mentioned include Additional Paid-In Capital and Retained Earnings as of March 31, 2025.
What is the SIC code for Ocular Therapeutix, Inc.?
The Standard Industrial Classification (SIC) code for Ocular Therapeutix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding OCULAR THERAPEUTIX, INC (OCUL).